ImmuCell Corporation

5.06-0.0400-0.78%Vol 11 0691Y Perf -34.47%
Nov 11th, 2019 15:58
BID5.06 ASK5.26
Open5.10 Previous Close5.10
Pre-Market- After-Market-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★★     57.57
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     45.81
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (M)36 
Earnings Rating
Neutral
Price Range Ratio 52W %
10.06 
Earnings Date
11th Nov 2019

Today's Price Range

4.805.24

52W Range

4.708.28

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
-4.17%
1 Month
-0.78%
3 Months
-15.95%
6 Months
-20.69%
1 Year
-34.47%
3 Years
-1.94%
5 Years
6.08%
10 Years
34.93%

TickerPriceChg.Chg.%
ICCC5.06-0.0400-0.78
AAPL262.202.06000.79
GOOG1 299.19-12.1800-0.93
MSFT146.110.15000.10
XOM70.34-0.4300-0.61
WFC54.05-0.0500-0.09
JNJ131.98-1.0200-0.77
FB189.61-1.2300-0.64
GE11.35-0.1700-1.48
JPM129.92-0.4600-0.35
Earnings HistoryEstimateReportedSurprise %
Q02 2016-0.00-
Q01 2016-0.11-
Q04 2015-0.09-
Q03 2015-0.11-
Q02 2015-0.03-
Q01 2015-0.15-
Q04 2014-0.04-
Q03 2014-0.00-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume11 069
Shares Outstanding (K)7 210
Trades Count35
Dollar Volume51 931
Avg. Volume7 488
Avg. Weekly Volume5 734
Avg. Monthly Volume5 499
Avg. Quarterly Volume6 798
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies.

CEO: Micheal F. Brigham

Teplephone: +1 207 878-2770

Address: 56 Evergreen Drive, Portland 04103, ME, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

81%19%

News

Stocktwits